StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cardiol Therapeutics's market cap was $87.86M on Nov 11, 2026, against $75.15M a year earlier. Over the last 5 years it ranged from $22.04M to $171.80M, with a median of $75.15M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$87.86M+28.7%
2025Dec 31, 2025$68.26M-17.3%
2024Dec 31, 2024$82.51M+56.6%
2023Dec 29, 2023$52.71M+139.1%
2022Dec 30, 2022$22.04M-60.1%
2021Dec 31, 2021$55.24M–

More Cardiol Therapeutics figures

See a number that looks wrong?